Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Silvia Margarita García-Acuña"'
Autor:
Yoel Z. Betancor, Miriam Ferreiro-Pantín, Urbano Anido-Herranz, Mar Fuentes-Losada, Luis León-Mateos, Silvia Margarita García-Acuña, Vanessa Vaamonde-Rodríguez, Beatriz García-Pinel, Víctor Cebey-López, Rosa Villaverde-Viaño, Helena Lombardía-Rodríguez, Martin Kotrulev, Natalia Fernández-Díaz, Iria Gomez-Tourino, Carlos Fernández-Baltar, Jorge García-González, Jose M. C. Tubio, Rafael López-López, Juan Ruiz-Bañobre
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
In the advanced renal cell carcinoma (RCC) scenario, there are no consistent biomarkers to predict the clinical benefit patients derived from immune checkpoint blockade (ICB). Taking this into consideration, herein, we conducted a retrospective study
Externí odkaz:
https://doaj.org/article/3df50f215da44f60a777ca651a4ba236
Autor:
Miriam Ferreiro-Pantín, Urbano Anido-Herranz, Yoel Z. Betancor, Víctor Cebey-López, Luis León-Mateos, Jorge García-González, Silvia Margarita García-Acuña, Natalia Fernández-Díaz, Jose M. C. Tubio, Rafael López-López, Juan Ruiz-Bañobre
BackgroundIn the advanced urothelial carcinoma (aUC) scenario there are no consistent biomarkers to predict the benefit patients derived from immune checkpoint blockade. Recently a novel pan-tumor molecular tissue-based biomarker, the Immunotherapy R
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dc006b59288a791da1e8eedd00fe6d41
https://doi.org/10.1101/2023.04.11.23288423
https://doi.org/10.1101/2023.04.11.23288423
